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missing baseline drift in the images, an artificial tumor 
representation (ATR) was generated and placed in the 
healthy lung (see Fig.1).  
 
Its motion trajectory is equivalent to the one of the real 
tumor. For evaluation purposes a static drift of 20mm has 
been incorporated.  
Results: Tracking results were compared to reference data 
generated by manual tumor tracking (see Table 1).  
 
The mean error was 0.8mm in L-R and 0.6mm in S-I direction 
and the mean computational time accounted for 2.3ms. The 
accuracy of ATR tracking was compared to the ground-truth 
used for ATR generation. The mean error for normal ATR 
respiratory motion was 0.9mm (L-R) and 2.5mm (S-I) whereas 
with the baseline drift it accounted for 1.9mm (L-R) and 
5.3mm (S-I). 
Conclusions: A template matching based method for real-
time detection of lung tumor motion in projection images has 
been developed. The presented algorithm is robust against 
tumor overlaps and additional motion influence. Further 
evaluation of the presented approach on additional image 
data is required. The applicability of this method on other 
imaging modalities warrants further research. 
This research was carried out with the support of the German 
Research Foundation (DFG) as part of project C01, SFB/TRR 
125 Cognition-Guided Surgery. 
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Purpose/Objective: Accurate assessment of hilar and 
mediastinal lymph node (LN) status in NSCLC is essential for 
reliable TNM-staging and treatment decision-making on per-
patient basis (surgery vs. chemo-radiotherapy). Moreover, 
accurate staging of individual LNs is crucial for selective 
nodal irradiation. We therefore analysed the diagnostic value 
of MRI in detecting and differentiating (non-)metastatic 
regional LNs on both per-patient and per-nodal basis, in 
reference to cytology or histology, and compared it to that of 
FDG-PET/CT. 
Materials and Methods: A systematic literature search was 
performed in PubMed, Web of Science, Embase, and 
MEDLINE. The methodological quality was evaluated using 
QUADAS-2 and Deeks' funnel plots. Hierarchical summary ROC 
curves were generated to estimate the pooled diagnostic 
power of MRI in N-staging NSCLC [sensitivity, specificity, and 
diagnostic odds ratio (DOR)]. For comparison, data from four 
equivalent meta-analyses on FDG-PET/CT was used. Subgroup 
analyses, expressed as relative DOR (rDOR), were performed 
to evaluate whether publication year (before 2008 vs. 
thereafter) and method of evaluation (quantitative vs. 
qualitative) affected the overall diagnostic performance of 
MRI. 
Results: Of 2551 initially identified studies, 12 eligible 
studies were included in this meta-analysis. On per-patient 
basis, the pooled estimates [95% CI] for sensitivity, 
specificity, and DOR were 0.87 [0.78-0.92], 0.88 [0.77-0.94], 
and 48.1 [23.4-98.9], respectively. On per-nodal basis, the 
respective measures were 0.88 [0.78-0.94], 0.95 [0.87-0.98], 
and 129.5 [49.3-340.0]. These results are set against recently 
published FDG-PET/CT data revealing an average sensitivity 
and specificity of 0.74 and 0.89, respectively, on per-patient, 
and of 0.68 and 0.93, respectively, on per-nodal basis (Table 
1). Subgroup analyses showed an increased DOR for per-
patient based studies published after 2008, while the DOR 
decreased for per-nodal based studies. The discriminatory 
power of quantitative evaluation was significantly greater 
than qualitative evaluation on per-nodal basis (rDOR=7.25 
[1.75-30.09], P=0.01).  
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Conclusions: This meta-analysis demonstrates Level-II 
evidence of the high diagnostic performance of MRI in staging 
hilar/mediastinal LNs in NSCLC on both per-patient and per-
nodal basis. Relative to FDG-PET/CT, pulmonary MRI is able 
to reach higher sensitivity at similar specificity, encouraging 
future prospective studies on treatment decision-making and 
selective nodal irradiation in NSCLC. However, before 
pulmonary MRI can replace FDG-PET/CT in NSCLC 
radiotherapy, thorough assessment of geometric distortion in 
MR images is mandatory. 
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Purpose/Objective: The advantage of proton therapy is the 
presence of a sharp distal dose fall-off that can be used to 
spare normal tissues beyond the end of the delivered field. 
However, due to this sharp fall-off, even small errors 
resulting from patient misalignments could potentially result 
in a significant discrepancy between the planned and the 
delivered dose. Therefore, to tap the full potential of proton 
therapy, accurate and on-line methods to verify the patient 
positioning and the proton range during the treatment are 
desirable. Here we propose and validate a fast and innovative 
technique for determining shift and rotational positional 
uncertainties for proton therapy using what we call 'range 
probes'. A range probe is a narrow, high energy proton pencil 
beam that shoots through the patient and can be detected on 
exit and for which the residual range and shape of the Bragg 
peaks (BP) can be measured using a multi-layer-ionisation-
chamber (MLIC) (see Figure 1). By the use of a number of 
carefully selected range probe positions, the ranges of the 
detected BP's can uniquely define the orientation of the 
patient. 
Materials and Methods: To validate this approach, an 
anthropomorphic phantom has been used, and a planning CT 
acquired. From this, 700 new CT's were generated, assuming 
different rotations along each axis. Five low dose range 
probes with energy 177 MeV were then simulated to pass 
through all these CT data sets using the VMCPro Monte Carlo 
code, with the residual BP's of each range probe being stored 
in a database to which experimentally measured range probe 
BP's can be compared. The phantom was then placed on a 
rotation device and three new CT's with randomly generated 
rotations were acquired, representing three possible daily 
positioning's of the patient. To determine these 'daily' 
rotational positioning errors, range probes were simulated 
through these 'daily' CT data sets, and the results compared 
to the pre-calculated data base, from which the actual 'daily' 
rotational error could be determined. 
 
 
 
Results: In Table 1 the comparison between the predicted 
rotations and the daily errors are reported for the three 
studied cases. The calculation performed shows that a 
rotational positioning errors of the phantom can be detected 
with a resolution of about derror=1°. 
 
 
 
Conclusions: With this phantom study we have demonstrated 
the possible use of a small number of proton range probes for 
detecting on-line, residual rotational misalignments of 
patients with a high level of accuracy. The technique is fast 
and can effectively reconstruct three-dimensional positioning 
errors from a single proton beam angle. 
Even if further investigations and measurements are required 
before the method can be applied in clinical routine, our 
simulations and measurements have shown the feasibility of 
the approach. 
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Purpose/Objective: To report the clinical results of a five 
years experience in the neo-adjuvant treatment of rectal 
cancer within a moderate hypofractionated regimen (18 
